Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 96

1.

Noninvasive blood tests for fetal development predict gestational age and preterm delivery.

Ngo TTM, Moufarrej MN, Rasmussen MH, Camunas-Soler J, Pan W, Okamoto J, Neff NF, Liu K, Wong RJ, Downes K, Tibshirani R, Shaw GM, Skotte L, Stevenson DK, Biggio JR, Elovitz MA, Melbye M, Quake SR.

Science. 2018 Jun 8;360(6393):1133-1136. doi: 10.1126/science.aar3819.

PMID:
29880692
2.

Assessing the Impact of Growth Hormone Deficiency (GHD) in Adults: Interpreting Change of the Treatment-Related Impact Measure-Adult Growth Hormone Deficiency (TRIM-AGHD).

Brod M, Beck JF, Højbjerre L, Bushnell DM, Adalsteinsson JE, Wilkinson L, Rasmussen MH.

Pharmacoecon Open. 2018 May 23. doi: 10.1007/s41669-018-0082-3. [Epub ahead of print]

3.

Pharmacokinetics and Pharmacodynamics of Once-Weekly Somapacitan in Children and Adults: Supporting Dosing Rationales with a Model-Based Analysis of Three Phase I Trials.

Juul RV, Rasmussen MH, Agersø H, Overgaard RV.

Clin Pharmacokinet. 2018 Apr 18. doi: 10.1007/s40262-018-0662-5. [Epub ahead of print]

PMID:
29671202
4.

Safety and convenience of once-weekly somapacitan in adult GH deficiency: a 26-week randomized, controlled trial.

Johannsson G, Feldt-Rasmussen U, Håkonsson IH, Biering H, Rodien P, Tahara S, Toogood A, Rasmussen MH; REAL 2 Study Group.

Eur J Endocrinol. 2018 May;178(5):491-499. doi: 10.1530/EJE-17-1073. Epub 2018 Mar 2.

5.

The incidence of bent dorsal fins in free-ranging cetaceans.

Alves F, Towers JR, Baird RW, Bearzi G, Bonizzoni S, Ferreira R, Halicka Z, Alessandrini A, Kopelman AH, Yzoard C, Rasmussen MH, Bertulli CG, Jourdain E, Gullan A, Rocha D, Hupman K, Mrusczok MT, Samarra FIP, Magalhães S, Weir CR, Ford JKB, Dinis A.

J Anat. 2018 Feb;232(2):263-269. doi: 10.1111/joa.12729. Epub 2017 Nov 17.

PMID:
29148044
6.

Risk, treatment duration, and recurrence risk of postpartum affective disorder in women with no prior psychiatric history: A population-based cohort study.

Rasmussen MH, Strøm M, Wohlfahrt J, Videbech P, Melbye M.

PLoS Med. 2017 Sep 26;14(9):e1002392. doi: 10.1371/journal.pmed.1002392. eCollection 2017 Sep.

7.

A genetically inducible porcine model of intestinal cancer.

Callesen MM, Árnadóttir SS, Lyskjaer I, Ørntoft MW, Høyer S, Dagnaes-Hansen F, Liu Y, Li R, Callesen H, Rasmussen MH, Berthelsen MF, Thomsen MK, Schweiger PJ, Jensen KB, Laurberg S, Ørntoft TF, Elverløv-Jakobsen JE, Andersen CL.

Mol Oncol. 2017 Nov;11(11):1616-1629. doi: 10.1002/1878-0261.12136. Epub 2017 Oct 10.

8.

Somapacitan, a once-weekly reversible albumin-binding GH derivative, in children with GH deficiency: A randomized dose-escalation trial.

Battelino T, Rasmussen MH, De Schepper J, Zuckerman-Levin N, Gucev Z, Sävendahl L; NN8640-4042 Study Group.

Clin Endocrinol (Oxf). 2017 Oct;87(4):350-358. doi: 10.1111/cen.13409. Epub 2017 Aug 8.

PMID:
28656605
9.

Molecular-Subtype-Specific Biomarkers Improve Prediction of Prognosis in Colorectal Cancer.

Bramsen JB, Rasmussen MH, Ongen H, Mattesen TB, Ørntoft MW, Árnadóttir SS, Sandoval J, Laguna T, Vang S, Øster B, Lamy P, Madsen MR, Laurberg S, Esteller M, Dermitzakis ET, Ørntoft TF, Andersen CL.

Cell Rep. 2017 May 9;19(6):1268-1280. doi: 10.1016/j.celrep.2017.04.045.

10.

Understanding Treatment Burden for Children Treated for Growth Hormone Deficiency.

Brod M, Højbjerre L, Alolga SL, Beck JF, Wilkinson L, Rasmussen MH.

Patient. 2017 Oct;10(5):653-666. doi: 10.1007/s40271-017-0237-9.

11.

Minimal variation in anti-A and -B titers among healthy volunteers over time: Implications for the use of out-of-group blood components.

Sprogøe U, Yazer MH, Rasmussen MH, Antonsen B, Bistrup C, Assing K.

J Trauma Acute Care Surg. 2017 Jun;82(6S Suppl 1):S87-S90. doi: 10.1097/TA.0000000000001432.

PMID:
28333830
12.

Understanding burden of illness for child growth hormone deficiency.

Brod M, Alolga SL, Beck JF, Wilkinson L, Højbjerre L, Rasmussen MH.

Qual Life Res. 2017 Jul;26(7):1673-1686. doi: 10.1007/s11136-017-1529-1. Epub 2017 Feb 28.

13.

Highly Directional Sonar Beam of Narwhals (Monodon monoceros) Measured with a Vertical 16 Hydrophone Array.

Koblitz JC, Stilz P, Rasmussen MH, Laidre KL.

PLoS One. 2016 Nov 9;11(11):e0162069. doi: 10.1371/journal.pone.0162069. eCollection 2016.

14.

Putting a brake on stress signaling: miR-625-3p as a biomarker for choice of therapy in colorectal cancer.

Lyskjær I, Rasmussen MH, Andersen CL.

Epigenomics. 2016 Nov;8(11):1449-1452. Epub 2016 Oct 25. No abstract available.

15.

miRNA profiling of circulating EpCAM(+) extracellular vesicles: promising biomarkers of colorectal cancer.

Ostenfeld MS, Jensen SG, Jeppesen DK, Christensen LL, Thorsen SB, Stenvang J, Hvam ML, Thomsen A, Mouritzen P, Rasmussen MH, Nielsen HJ, Ørntoft TF, Andersen CL.

J Extracell Vesicles. 2016 Aug 29;5:31488. doi: 10.3402/jev.v5.31488. eCollection 2016.

16.

miR-625-3p regulates oxaliplatin resistance by targeting MAP2K6-p38 signalling in human colorectal adenocarcinoma cells.

Rasmussen MH, Lyskjær I, Jersie-Christensen RR, Tarpgaard LS, Primdal-Bengtson B, Nielsen MM, Pedersen JS, Hansen TP, Hansen F, Olsen JV, Pfeiffer P, Ørntoft TF, Andersen CL.

Nat Commun. 2016 Aug 16;7:12436. doi: 10.1038/ncomms12436.

17.

Reversible Albumin-Binding GH Possesses a Potential Once-Weekly Treatment Profile in Adult Growth Hormone Deficiency.

Rasmussen MH, Janukonyté J, Klose M, Marina D, Tanvig M, Nielsen LF, Höybye C, Andersen M, Feldt-Rasmussen U, Christiansen JS.

J Clin Endocrinol Metab. 2016 Mar;101(3):988-98. doi: 10.1210/jc.2015-1991. Epub 2016 Jan 4.

18.

Humpback whale (Megaptera novaeangliae) song unit and phrase repertoire progression on a subarctic feeding ground.

Magnúsdóttir EE, Miller PJ, Lim R, Rasmussen MH, Lammers MO, Svavarsson J.

J Acoust Soc Am. 2015 Nov;138(5):3362-74. doi: 10.1121/1.4935517.

PMID:
26627808
19.

Assessing The Treatment Burden for Growth Hormone Deficiency (Ghd) In Children: Concept Elicitation Results Supporting The Development of The Treatment Burden Measure for Childhood Ghd (Tb-Cghd).

Brod M, Højbjerre L, Wilkinson L, Alolga SL, Rasmussen MH.

Value Health. 2015 Nov;18(7):A676. doi: 10.1016/j.jval.2015.09.1999. Epub 2015 Oct 20. No abstract available.

20.

Assessing The Impact of Growth Hormone Deficiency (Ghd) In Children: Concept Elicitation Results Supporting The Development of The Treatment-Related Impact Measure for Childhood Ghd (Trim-Cghd).

Brod M, Højbjerre L, Wilkinson L, Alolga SL, Rasmussen MH.

Value Health. 2015 Nov;18(7):A674. doi: 10.1016/j.jval.2015.09.1990. Epub 2015 Oct 20. No abstract available.

Supplemental Content

Loading ...
Support Center